Business UpdateAug 12, 2026, 04:09 PM
Brainsway: 8.5M+ Deep TMS Sessions, 1,950 Systems Installed
AI Summary
Brainsway Ltd. filed an investor deck, showcasing its leadership in the interventional psychiatry market with its Deep TMS technology. The company has delivered over 8.5 million Deep TMS sessions and boasts 1,950 systems installed globally, covering 48 US states and 6 continents. Brainsway highlights its four FDA indications and the substantial, underpenetrated market opportunity, with over 300 million covered lives and a global TAM exceeding $15 billion.
Key Highlights
- Over 8.5 million Deep TMS sessions delivered to date.
- 1,950 Deep TMS systems installed across 48 US states and 6 continents.
- Company holds 4 FDA indications for its Deep TMS platform.
- Reimbursement covers over 300 million lives.
- Global Interventional Psychiatry Total Addressable Market (TAM) exceeds $15 billion.
- US depression market opportunity is approximately $4 billion.
- Current market penetration is less than 2%.
- Over 170 million untreated patients exist across current partner markets.
Price Impact
More from BWAY